CHIARADONNA, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 8.147
EU - Europa 7.451
AS - Asia 4.806
SA - Sud America 691
AF - Africa 136
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.253
Nazione #
US - Stati Uniti d'America 7.904
SE - Svezia 2.202
SG - Singapore 1.689
IT - Italia 1.592
CN - Cina 1.180
DE - Germania 1.050
RU - Federazione Russa 682
VN - Vietnam 564
HK - Hong Kong 522
BR - Brasile 519
PL - Polonia 345
IE - Irlanda 283
GB - Regno Unito 270
FR - Francia 263
CA - Canada 173
IN - India 172
UA - Ucraina 171
FI - Finlandia 150
NL - Olanda 105
KR - Corea 92
TR - Turchia 92
ID - Indonesia 82
AT - Austria 74
BD - Bangladesh 74
AR - Argentina 68
DK - Danimarca 65
IQ - Iraq 51
JP - Giappone 51
ES - Italia 49
ZA - Sudafrica 49
MX - Messico 46
CH - Svizzera 33
BE - Belgio 32
SA - Arabia Saudita 27
PK - Pakistan 24
EC - Ecuador 23
PH - Filippine 23
IR - Iran 21
UZ - Uzbekistan 21
CO - Colombia 19
MA - Marocco 19
CZ - Repubblica Ceca 16
VE - Venezuela 15
JO - Giordania 14
CL - Cile 13
PY - Paraguay 13
TN - Tunisia 13
EG - Egitto 12
TW - Taiwan 12
AU - Australia 11
NP - Nepal 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
MY - Malesia 9
PE - Perù 9
UY - Uruguay 9
AZ - Azerbaigian 8
PT - Portogallo 8
AL - Albania 7
KE - Kenya 7
KG - Kirghizistan 7
LT - Lituania 7
LU - Lussemburgo 7
PS - Palestinian Territory 7
ET - Etiopia 6
GR - Grecia 6
HU - Ungheria 6
JM - Giamaica 6
LB - Libano 6
OM - Oman 6
RO - Romania 6
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
KZ - Kazakistan 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BO - Bolivia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
MN - Mongolia 3
NI - Nicaragua 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
QA - Qatar 2
RS - Serbia 2
Totale 21.231
Città #
Stockholm 1.882
Ann Arbor 1.229
Singapore 1.016
Ashburn 779
Frankfurt am Main 696
San Jose 554
Woodbridge 501
Milan 499
Hong Kong 491
Fairfield 404
Wilmington 342
Chandler 336
Houston 291
Kraków 280
Dublin 275
Dallas 237
Beijing 198
New York 188
Los Angeles 169
Jacksonville 168
Dearborn 167
Seattle 162
Ho Chi Minh City 160
Hefei 159
Santa Clara 155
Cambridge 146
Munich 132
Chicago 121
The Dalles 121
Hanoi 118
Seoul 87
Princeton 84
Council Bluffs 80
Buffalo 78
Helsinki 77
Lauterbourg 70
Jakarta 66
Nanjing 62
Shanghai 60
São Paulo 60
Moscow 52
Vienna 51
Dong Ket 49
Rome 48
Guangzhou 45
Boardman 44
Warsaw 44
Lawrence 42
Toronto 40
Montréal 38
San Diego 37
Tokyo 35
Altamura 32
Cento 32
Montreal 32
Orem 32
Chennai 31
Johannesburg 31
Denver 30
Brussels 29
Nuremberg 29
Atlanta 28
Da Nang 28
Lachine 28
Baghdad 25
Bologna 25
London 25
Nanchang 25
Turin 24
Poplar 22
Brooklyn 21
Tianjin 21
Amsterdam 20
Torino 20
Ankara 19
Zhengzhou 19
Andover 18
Falls Church 18
Naples 18
Paris 18
Zurich 18
Hyderabad 17
Manchester 17
Rio de Janeiro 17
Salt Lake City 17
Tashkent 17
Kent 16
Brusuglio 14
Dhaka 14
Kunming 14
Amman 13
Boston 13
Hebei 13
Huizen 13
Lappeenranta 13
Mumbai 13
Phoenix 13
Sacramento 13
Bexley 12
Querétaro 12
Totale 14.214
Nome #
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 2.675
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 700
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 672
Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells 529
Design, Synthesis, and Preliminary Biological Evaluation of GlcNAc-6P Analogues for the Modulation of Phosphoacetylglucosamine Mutase 1 (AGM1/PGM3) 484
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 463
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring. 453
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation 442
Central metabolism of functionally heterogeneous mesenchymal stromal cells 399
From cancer metabolism to new biomarkers and drug targets 396
Mitochondria in Focus: Targeting the Cell-Death Mechanism 377
Analysis of mitochondrial metabolism in situ: Combining stable isotope labeling with selective permeabilization 376
Transcriptional profiling of immortalized and K-ras-transformed mouse fibroblasts upon PKA stimulation by forskolin in low glucose availability 363
RAS and PKA pathways in cancer: new insight from transcriptional analysis 354
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 353
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 334
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor 328
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells 327
Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts 324
Ras-dependent carbon metabolism and transformation in mouse fibroblasts 314
Metabolic reprogramming and dysregulated metabolism: Cause, consequence and/or enabler of environmental carcinogenesis? 309
Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes 308
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 299
Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS 298
New Insights into the Connection between Histone Deacetylases, Cell Metabolism, and Cancer 295
Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes 290
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response 289
Glutamine deprivation induces abortive S-phase rescued by deoxyribonucleotides in K-ras transformed fibroblasts 277
The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies 277
Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration 272
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 270
Cancer Metabolism as a New Real Target in Tumor Therapy 270
Acquired glucose sensitivity of k-ras transformed fibroblasts 269
Genetic and Molecular Characterization of The Human Osteosarcoma 3AB-OS Cancer Stem Cell Line: A Possible Model For Studying Osteosarcoma Origin and Stemness 264
Systems biology and the molecular circuits of cancer 262
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 258
Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells 256
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 255
Mitochondrial Complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death 255
Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation 253
Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer 253
Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells 251
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer 249
PKA stimulation protects K-ras transformed cells from apoptosis induced by glucose depletion reactivating mitochondrial function 244
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials 236
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 229
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis 222
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 212
Glucose shortage dependent apoptosis in transformed cells upon activation of UPR-autophagy pathway 204
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 195
Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2 189
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 189
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 184
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 183
Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism 172
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 169
VITAMIN D SUPPLEMENTATION MAY IMPROVE COVID-19 PROGNOSIS? EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS 168
PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 158
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 152
Inhibition of the Hexosamine Biosynthetic Pathway Enhances Enzalutamide Response in Prostate Cancer Cells 138
Comparative transcriptional analysis between a K-ras cell model of transformation and the NCI60 human cancer cells collection 137
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 130
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 128
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 123
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 119
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 111
High throughput metabolomics analysis in normal and K-Ras transformed murine fibroblasts 110
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 86
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 85
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 83
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 83
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 82
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 74
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 72
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 72
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 68
Histone glycation: a novel epigenetic target in breast cancer 49
null 3
Totale 21.801
Categoria #
all - tutte 55.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021482 0 0 0 0 0 0 0 0 0 154 125 203
2021/20221.055 107 94 124 110 87 91 59 43 53 43 101 143
2022/20231.440 157 403 162 156 104 183 11 78 102 6 59 19
2023/2024975 24 38 27 79 100 217 203 44 65 34 23 121
2024/20253.104 176 254 296 141 214 140 255 156 265 447 307 453
2025/20269.929 737 467 770 940 1.139 852 1.225 357 848 2.594 0 0
Totale 21.801